Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51

1.

Mild cognitive impairment: baseline and longitudinal structural MR imaging measures improve predictive prognosis.

McEvoy LK, Holland D, Hagler DJ Jr, Fennema-Notestine C, Brewer JB, Dale AM; Alzheimer's Disease Neuroimaging Initiative.

Radiology. 2011 Jun;259(3):834-43. doi: 10.1148/radiol.11101975. Epub 2011 Apr 6.

2.

Bias in tensor based morphometry Stat-ROI measures may result in unrealistic power estimates.

Thompson WK, Holland D; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2011 Jul 1;57(1):1-4. doi: 10.1016/j.neuroimage.2010.11.092. Epub 2011 Feb 22.

3.

Neuroimaging enrichment strategy for secondary prevention trials in Alzheimer disease.

McEvoy LK, Edland SD, Holland D, Hagler DJ Jr, Roddey JC, Fennema-Notestine C, Salmon DP, Koyama AK, Aisen PS, Brewer JB, Dale AM; Alzheimerʼs Disease Neuroimaging Initiative.

Alzheimer Dis Assoc Disord. 2010 Jul-Sep;24(3):269-77. doi: 10.1097/WAD.0b013e3181d1b814.

4.

Highly accurate inverse consistent registration: a robust approach.

Reuter M, Rosas HD, Fischl B.

Neuroimage. 2010 Dec;53(4):1181-96. doi: 10.1016/j.neuroimage.2010.07.020. Epub 2010 Jul 14.

5.

Six-month atrophy in MTL structures is associated with subsequent memory decline in elderly controls.

Murphy EA, Holland D, Donohue M, McEvoy LK, Hagler DJ Jr, Dale AM, Brewer JB; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2010 Dec;53(4):1310-7. doi: 10.1016/j.neuroimage.2010.07.016. Epub 2010 Jul 13.

6.

Relations between brain tissue loss, CSF biomarkers, and the ApoE genetic profile: a longitudinal MRI study.

Tosun D, Schuff N, Truran-Sacrey D, Shaw LM, Trojanowski JQ, Aisen P, Peterson R, Weiner MW; Alzheimer's Disease Neuroimaging Initiative.

Neurobiol Aging. 2010 Aug;31(8):1340-54. doi: 10.1016/j.neurobiolaging.2010.04.030. Epub 2010 Jun 8.

7.

Relationship between regional atrophy rates and cognitive decline in mild cognitive impairment.

McDonald CR, Gharapetian L, McEvoy LK, Fennema-Notestine C, Hagler DJ Jr, Holland D, Dale AM; Alzheimer's Disease Neuroimaging Initiative.

Neurobiol Aging. 2012 Feb;33(2):242-53. doi: 10.1016/j.neurobiolaging.2010.03.015. Epub 2010 May 14.

8.

Update on the magnetic resonance imaging core of the Alzheimer's disease neuroimaging initiative.

Jack CR Jr, Bernstein MA, Borowski BJ, Gunter JL, Fox NC, Thompson PM, Schuff N, Krueger G, Killiany RJ, Decarli CS, Dale AM, Carmichael OW, Tosun D, Weiner MW; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2010 May;6(3):212-20. doi: 10.1016/j.jalz.2010.03.004. Review.

9.

Cortical gray matter atrophy in healthy aging cannot be explained by undetected incipient cognitive disorders: a comment on Burgmans et al. (2009).

Fjell AM, Westlye LT, Espeseth T, Reinvang I, Dale AM, Holland D, Walhovd KB.

Neuropsychology. 2010 Mar;24(2):258-63; discussion 264-266. doi: 10.1037/a0018827.

10.

CSF biomarkers in prediction of cerebral and clinical change in mild cognitive impairment and Alzheimer's disease.

Fjell AM, Walhovd KB, Fennema-Notestine C, McEvoy LK, Hagler DJ, Holland D, Brewer JB, Dale AM; Alzheimer's Disease Neuroimaging Initiative.

J Neurosci. 2010 Feb 10;30(6):2088-101. doi: 10.1523/JNEUROSCI.3785-09.2010.

11.

Mapping Alzheimer's disease progression in 1309 MRI scans: power estimates for different inter-scan intervals.

Hua X, Lee S, Hibar DP, Yanovsky I, Leow AD, Toga AW, Jack CR Jr, Bernstein MA, Reiman EM, Harvey DJ, Kornak J, Schuff N, Alexander GE, Weiner MW, Thompson PM; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2010 May 15;51(1):63-75. doi: 10.1016/j.neuroimage.2010.01.104. Epub 2010 Feb 6.

12.

Brain atrophy in healthy aging is related to CSF levels of Aβ1-42.

Fjell AM, Walhovd KB, Fennema-Notestine C, McEvoy LK, Hagler DJ, Holland D, Blennow K, Brewer JB, Dale AM; Alzheimer's Disease Neuroimaging Initiative.

Cereb Cortex. 2010 Sep;20(9):2069-79. doi: 10.1093/cercor/bhp279. Epub 2010 Jan 4.

13.

Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization.

Petersen RC, Aisen PS, Beckett LA, Donohue MC, Gamst AC, Harvey DJ, Jack CR Jr, Jagust WJ, Shaw LM, Toga AW, Trojanowski JQ, Weiner MW.

Neurology. 2010 Jan 19;74(3):201-9. doi: 10.1212/WNL.0b013e3181cb3e25. Epub 2009 Dec 30.

14.

Robust atrophy rate measurement in Alzheimer's disease using multi-site serial MRI: tissue-specific intensity normalization and parameter selection.

Leung KK, Clarkson MJ, Bartlett JW, Clegg S, Jack CR Jr, Weiner MW, Fox NC, Ourselin S; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2010 Apr 1;50(2):516-23. doi: 10.1016/j.neuroimage.2009.12.059. Epub 2009 Dec 23.

15.

Bias in estimation of hippocampal atrophy using deformation-based morphometry arises from asymmetric global normalization: an illustration in ADNI 3 T MRI data.

Yushkevich PA, Avants BB, Das SR, Pluta J, Altinay M, Craige C; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2010 Apr 1;50(2):434-45. doi: 10.1016/j.neuroimage.2009.12.007. Epub 2009 Dec 31.

16.

Subregional neuroanatomical change as a biomarker for Alzheimer's disease.

Holland D, Brewer JB, Hagler DJ, Fennema-Notestine C, Dale AM; Alzheimer's Disease Neuroimaging Initiative.

Proc Natl Acad Sci U S A. 2009 Dec 8;106(49):20954-9. Erratum in: Proc Natl Acad Sci U S A. 2010 Apr 6;107(14):6551. Fenema-Notestine, Christine [corrected to Fennema-Notestine, Christine].

17.

One-year brain atrophy evident in healthy aging.

Fjell AM, Walhovd KB, Fennema-Notestine C, McEvoy LK, Hagler DJ, Holland D, Brewer JB, Dale AM.

J Neurosci. 2009 Dec 2;29(48):15223-31. doi: 10.1523/JNEUROSCI.3252-09.2009.

18.

Prognostic significance of growth kinetics in newly diagnosed glioblastomas revealed by combining serial imaging with a novel biomathematical model.

Wang CH, Rockhill JK, Mrugala M, Peacock DL, Lai A, Jusenius K, Wardlaw JM, Cloughesy T, Spence AM, Rockne R, Alvord EC Jr, Swanson KR.

Cancer Res. 2009 Dec 1;69(23):9133-40. doi: 10.1158/0008-5472.CAN-08-3863. Epub 2009 Nov 24.

19.

Regional rates of neocortical atrophy from normal aging to early Alzheimer disease.

McDonald CR, McEvoy LK, Gharapetian L, Fennema-Notestine C, Hagler DJ Jr, Holland D, Koyama A, Brewer JB, Dale AM; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2009 Aug 11;73(6):457-65. doi: 10.1212/WNL.0b013e3181b16431.

20.

Comparing registration methods for mapping brain change using tensor-based morphometry.

Yanovsky I, Leow AD, Lee S, Osher SJ, Thompson PM.

Med Image Anal. 2009 Oct;13(5):679-700. doi: 10.1016/j.media.2009.06.002. Epub 2009 Jun 24.

Supplemental Content

Support Center